Alawi A Alsheikh-Ali Selected Research

Left Ventricular Dysfunction

1/2018	Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
12/2017	β-Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In-Hospital and 12-Month Outcome: Results From the GULF-RACE 2 (Gulf Registry of Acute Coronary Events-2).
6/2004	Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alawi A Alsheikh-Ali Research Topics

Disease

10	Heart Failure 01/2022 - 09/2006
10	Myocardial Infarction 01/2021 - 08/2008
9	Stroke (Strokes) 01/2022 - 09/2010
8	Hypertension (High Blood Pressure) 01/2022 - 09/2006
8	ST Elevation Myocardial Infarction 04/2017 - 04/2010
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2009
6	Acute Coronary Syndrome 01/2020 - 01/2011
6	Rhabdomyolysis 03/2009 - 10/2004
5	Coronary Disease (Coronary Heart Disease) 01/2021 - 11/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2005
5	Neoplasms (Cancer) 06/2010 - 07/2007
4	Ventricular Tachycardia 01/2021 - 06/2008
4	Diabetes Mellitus 09/2020 - 03/2013
4	Atrial Fibrillation 11/2010 - 06/2004
3	Hemorrhage 01/2022 - 04/2010
3	Ventricular Fibrillation 01/2021 - 10/2009
3	Chest Pain (Chest Pains) 09/2020 - 03/2011
3	Left Ventricular Dysfunction 01/2018 - 06/2004
3	Cardiac Arrhythmias (Arrythmia) 01/2018 - 08/2008
3	Pathologic Constriction (Stenosis) 03/2017 - 09/2010
3	Dyslipidemias (Dyslipidemia) 01/2014 - 06/2005
3	Heart Arrest (Cardiac Arrest) 02/2013 - 10/2009
2	Vascular Diseases (Vascular Disease) 01/2022 - 12/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 04/2010
2	Cardiogenic Shock 01/2021 - 01/2020
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2020 - 04/2013
2	Tachycardia (Tachyarrhythmias) 09/2020 - 06/2004
2	Shock 09/2020 - 11/2019
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 05/2017 - 02/2013
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2015 - 06/2008
1	Insulin Resistance 01/2021
1	Infarction (Infarctions) 09/2020
1	Transient Ischemic Attack 01/2020
1	Cicatrix (Scar) 09/2015
1	Sleep Apnea Syndromes (Sleep Apnea) 05/2015
1	Weight Loss (Weight Reduction) 05/2015
1	Angina Pectoris 04/2013
1	Bradycardia 04/2013
1	Thrombosis (Thrombus) 01/2013
1	Pericardial Effusion 01/2013
1	Brugada Syndrome 05/2012
1	Syncope (Fainting) 05/2012
1	Bundle-Branch Block (Fascicular Block) 09/2011
1	Ventricular Dysfunction 04/2011
1	Takotsubo Cardiomyopathy 04/2011
1	Ischemia 01/2011
1	Chronic Renal Insufficiency 01/2011
1	Inflammation (Inflammations) 09/2010

Drug/Important Bio-Agent (IBA)

13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 06/2005
6	LDL CholesterolIBA 01/2014 - 07/2007
6	oxidized low density lipoproteinIBA 12/2010 - 07/2007
5	LipidsIBA 01/2021 - 11/2006
5	CholesterolIBA 01/2019 - 02/2006
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018 - 06/2004
4	HDL CholesterolIBA 12/2010 - 02/2006
3	Simvastatin (Zocor)FDA LinkGeneric 04/2009 - 02/2007
3	EnzymesIBA 03/2009 - 06/2004
2	Pharmaceutical PreparationsIBA 01/2022 - 07/2007
2	omega-Chloroacetophenone (Mace)IBA 01/2020 - 01/2019
2	MetalsIBA 01/2013 - 03/2009
2	Ezetimibe (Zetia)FDA Link 04/2009 - 07/2007
2	Rosuvastatin Calcium (Crestor)FDA Link 04/2009 - 06/2005
2	Niacin (Nicotinic Acid)FDA LinkGeneric 04/2008 - 02/2007
2	Gemfibrozil (Lopid)FDA LinkGeneric 01/2008 - 10/2004
2	Fenofibrate (CiL)FDA LinkGeneric 01/2008 - 10/2004
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020
1	Clopidogrel (Plavix)FDA Link 11/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2017
1	HDL LipoproteinsIBA 10/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	AnticoagulantsIBA 01/2017
1	Theophylline (Theon)FDA LinkGeneric 05/2015
1	Warfarin (Coumadin)FDA LinkGeneric 05/2015
1	Blood Glucose (Blood Sugar)IBA 12/2014
1	IvabradineIBA 04/2013
1	CatecholaminesIBA 04/2011
1	CreatinineIBA 01/2011
1	Angiotensin Receptor AntagonistsIBA 01/2011
1	Glycoproteins (Glycoprotein)IBA 04/2010

Therapy/Procedure

24	Therapeutics 09/2020 - 06/2005
9	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020 - 06/2008
8	Percutaneous Coronary Intervention 09/2020 - 03/2009
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2017 - 03/2009
4	Defibrillators (Defibrillator) 01/2021 - 06/2008
4	Thrombolytic Therapy 09/2020 - 04/2010
3	Secondary Prevention 02/2013 - 06/2005
2	Length of Stay 11/2019 - 12/2012
2	Stents 01/2013 - 03/2009
2	Radiofrequency Ablation 01/2013 - 11/2010
2	Catheter Ablation 11/2010 - 08/2009
1	Patient Readmission 01/2020
1	Blood Transfusion (Blood Transfusions) 01/2019
1	Drug Therapy (Chemotherapy) 12/2018
1	Critical Care (Surgical Intensive Care) 01/2016
1	Cardiac Resynchronization Therapy 09/2015
1	Continuous Positive Airway Pressure 05/2015
1	Contraindications 09/2010